What misconceptions about therapies for autism are common?
Families often encounter conflicting information about autism therapies. High-quality reviews including BMJ 2023 and JAMA Pediatrics 2024 show that many assumptions about “what works” are either unproven or overstated. Understanding these misconceptions helps families make informed, rights-based decisions aligned with NHS and NICE guidance.
Misconception 1: “More therapy hours always lead to better outcomes”
Evidence does not support the common claim that 20–40 hours per week guarantees progress. The JAMA Pediatrics analysis found that recommendations for intensive schedules are “sparse” in evidence and show no reliable dose–response effect. BMJ Project AIM similarly reported no significant benefits when trials with lower bias were examined.
Misconception 2: “Autism can be cured with the right therapy”
According to the NHS, autism is a lifelong neurodevelopmental difference, not an illness to cure as updated in (NHS: everyday life). The National Autistic Society emphasises that interventions should never aim to “treat autism,” but instead support wellbeing and daily functioning (NAS interventions overview). WHO guidance confirms the same.
Misconception 3: “ABA and intensive behavioural programmes are universally evidence-based and safe”
NICE has reviewed ABA/EIBI evidence several times and does not endorse any intensive package due to limited and inconsistent findings (NICE evidence summary). Surveillance reports note stakeholders concern that ABA “has the potential to cause harm,” while high-quality reviews show that adverse events are rarely measured. Qualitative studies also describe some autistic adults experiencing intensive, compliance-based ABA as distressing or traumatic.
Misconception 4: “Therapy should aim to normalise autistic behaviour”
UK professional bodies strongly reject this model. RCSLT’s autism guidance states that support should be strength-based and preserve “autistic ways of being” (RCSLT autism guidance). RCOT guidance similarly emphasises accepting autism as natural human variation, highlighting the harms of masking and pressure to “fit in.”
Misconception 5: “Children must comply for therapy to work”
Research on assent shows that uncoerced participation is key to emotional safety. Studies from assent-based approaches recommend monitoring assent and adapting sessions when children show distress or resistance. Autistic adults have reported that enforced compliance in childhood led to anxiety and difficulties with boundaries.
Misconception 6: “Lack of progress means therapy should be intensified”
Analyses in JAMA Pediatrics and BMJ Project AIM show that escalating intensity rarely improves outcomes and may reduce essential time for rest, family life and sensory recovery.
Misconception 7: “All autism therapies are evidence-based”
NICE explicitly advises against a range of biomedical or alternative treatments, including chelation, restrictive diets for core autism features, hormone therapies and hyperbaric oxygen due to lack of benefit and safety concerns as shown in NICE CG170.
Key takeaway
The strongest evidence shows that autism therapies should prioritise wellbeing, autonomy and participation, not normalisation, cure, or intensity for its own sake. A personalised, rights-based approach aligned with, NHS and NICE guidance offers the safest and most meaningful support.
